{"product_id":"colgatepalmolive-swot-analysis","title":"Colgate-Palmolive SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMake Insightful Decisions Backed by Expert Research\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eColgate-Palmolive's strong global brand, resilient oral-care franchise, and efficient supply chain underpin steady cash flow and defensive market positioning, while narrowing margins, commodity exposure, and intensifying competition create tangible risks; regulatory shifts and emerging-market growth present strategic opportunities. Purchase the full SWOT analysis to access a research-backed, editable report and Excel model for investor-ready strategy and planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDominant Global Oral Care Market Leadership\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs of December 31, 2025, Colgate-Palmolive holds over 41% of the global toothpaste market and roughly 32% of manual toothbrushes, giving it clear category leadership. This scale drove gross margins above 56% in oral care in 2025 and enabled promotional spend efficiencies versus smaller rivals. The position secures strong shelf placement with major retailers and supports household penetration exceeding 70% in key markets. Such dominance strengthens bargaining power and lowers per-unit costs globally.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResilient and High-Growth Pet Nutrition Segment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Hill’s Pet Nutrition brand has become a critical growth engine, reaching nearly 24% of Colgate-Palmolive’s total sales by Q4 2025 and delivering premium gross margins above the company average; the segment stays resilient despite broader market volatility. Driven by the humanization of pets trend, Hill’s sustains higher ASPs (average selling prices) and recurring demand. Strategic buys, including the 2025 Prime100 acquisition, expanded Hill’s into the fast-growing fresh pet food category and boosted top-line growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRobust Financial Health and Cash Flow Generation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpcolgate-palmolive reported record net cash from operations of about billion for full-year signaling exceptional financial stability and liquidity.\u003e\n\u003cpthis cash strength backs shareholder returns including more than consecutive years of dividend payments and sustained share buybacks.\u003e\n\u003cpthe company posts a high return on invested capital above its weighted average cost of indicating efficient allocation and consistent value creation.\u003e\n\u003c\/pthe\u003e\u003c\/pthis\u003e\u003c\/pcolgate-palmolive\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExtensive Emerging Market Penetration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eColgate-Palmolive operates in over 200 countries and earned about 45% of revenue from emerging markets in 2024, with strong exposure to Latin America and Asia, which cushions the company from country-specific downturns.\u003c\/p\u003e\n\u003cp\u003eExpanding middle classes in India and Brazil offer sizable growth runway; Colgate’s long-standing rural distribution networks in those countries create high barriers for new entrants.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~200 countries footprint\u003c\/li\u003e\n\u003cli\u003e45% revenue from emerging markets (2024)\u003c\/li\u003e\n\u003cli\u003eFocus: Latin America, Asia\u003c\/li\u003e\n\u003cli\u003eRural distribution in India\/Brazil = strong barrier\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommitment to Science-Led Innovation and R\u0026amp;D\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eColgate-Palmolive’s R\u0026amp;D focus fuels premium, science-backed launches like the 2024 Purple Range whitening line in Asia and ActiveBiome+ for pet nutrition, supporting higher margins and retailer placement.\u003c\/p\u003e\n\u003cp\u003eR\u0026amp;D spend was about $517 million in FY2024 (≈1.8% of sales), helping defend share versus P\u0026amp;G and digital-native brands through faster innovation cycles and clear efficacy claims.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 R\u0026amp;D: $517M (≈1.8% sales)\u003c\/li\u003e\n\u003cli\u003ePurple Range: premium whitening push in Asia, 2024 launch\u003c\/li\u003e\n\u003cli\u003eActiveBiome+: enables premium pricing in pet segment\u003c\/li\u003e\n\u003cli\u003eStrength: innovation shields share vs P\u0026amp;G and DNVBs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eColgate-Palmolive: Oral Care Dominance, Hill’s Growth \u0026amp; $4.2B FY2025 Cash\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eColgate-Palmolive leads global oral care (≈41% toothpaste, ≈32% manual toothbrushes, 2025), driving \u0026gt;56% oral gross margins and \u0026gt;70% household penetration in key markets; Hill’s Pet Nutrition reached ~24% of sales by Q4 2025 with premium margins after the 2025 Prime100 deal; FY2025 operating cash ~ $4.2B, 45% revenue from emerging markets (2024), R\u0026amp;D $517M (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eToothpaste share (2025)\u003c\/td\u003e\n\u003ctd\u003e≈41%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManual toothbrush share (2025)\u003c\/td\u003e\n\u003ctd\u003e≈32%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHill’s share of sales (Q4 2025)\u003c\/td\u003e\n\u003ctd\u003e~24%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOperating cash (FY2025)\u003c\/td\u003e\n\u003ctd\u003e$4.2B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEmerging markets revenue (2024)\u003c\/td\u003e\n\u003ctd\u003e45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend (2024)\u003c\/td\u003e\n\u003ctd\u003e$517M (≈1.8% sales)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a clear SWOT framework analyzing Colgate-Palmolive’s internal strengths and weaknesses alongside external opportunities and threats, outlining the strategic factors that shape its competitive position and future growth prospects.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise Colgate-Palmolive SWOT snapshot for rapid strategic alignment and stakeholder-ready summaries.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHeavy Dependence on the Oral Care Category\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDespite pet nutrition growth, Colgate-Palmolive still derives about 45% of 2024 net sales from oral care (Colgate-Palmolive 2024 10-K), leaving the firm exposed if oral-care demand falls or price wars erupt with rivals like Procter \u0026amp; Gamble. \u003c\/p\u003e\n\u003cp\u003eIf innovation in toothpaste\/toothbrush lines slows, profit margins—oral care had ~18% operating margin in 2024—would hit consolidated EPS harder than more diversified peers. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSignificant GAAP Earnings Volatility Due to Impairments\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn late 2025 Colgate-Palmolive reported a sharp GAAP earnings decline, posting a fourth-quarter net loss driven largely by a $794 million impairment tied to its skin health business after weaker-than-expected sales in China and other markets.\u003c\/p\u003e\n\u003cp\u003eThat non-cash charge swung reported EPS negative for the quarter and reduced 2025 adjusted earnings per share reconciliation by roughly $0.85 per share.\u003c\/p\u003e\n\u003cp\u003eSuch impairments highlight execution risks from past acquisitions and can spur negative investor sentiment about management’s capital allocation and M\u0026amp;A discipline.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVulnerability to Private Label Encroachment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAs inflation persisted through 2025, shifting buying patterns saw private-label share in US personal-care rise to 23% (IRI, 2025), pressuring Colgate-Palmolive’s premium pricing in North America where it earns ~30% of revenue. Trade-downs forced higher promo spend—Colgate increased trade\/promotional allowances to 14.2% of net sales in FY2025—pressuring operating margin which fell to 16.1%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLagging Agility in Digital and DTC Channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eColgate-Palmolive is investing in digital transformation but trails agile DTC startups; in 2024 e-commerce accounted for ~8% of global sales versus 15–30% for digital-first peers.\u003c\/p\u003e\n\u003cp\u003eThe company’s large structure slows responses to trends like plastic-free packaging and hyper-personalized wellness, risking lost share in fast-growing niches.\u003c\/p\u003e\n\u003cp\u003eClosing the gap needs sustained capex and marketing spend, pressuring short-term margins—Colgate’s 2024 operating margin was 18.3%.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e8% e-commerce sales (2024)\u003c\/li\u003e\n\u003cli\u003e15–30% peer e-comm benchmark\u003c\/li\u003e\n\u003cli\u003e2024 operating margin 18.3%\u003c\/li\u003e\n\u003cli\u003eRequires sustained capex and marketing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOperational Complexity and Supply Chain Exposure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eOperating in over 200 countries creates high logistical complexity and supply-chain exposure; Colgate-Palmolive reported $17.9 billion net sales in 2024, so disruptions scale fast.\u003c\/p\u003e\n\u003cp\u003eGeopolitical tensions and shifting trade policies in late 2025 raised tariff risks that the company estimated could hit margins by hundreds of millions of dollars, forcing contingency costs.\u003c\/p\u003e\n\u003cp\u003eContinuous restructuring and sourcing adjustments divert management attention from core growth initiatives and innovation.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e200+ countries: complex logistics\u003c\/li\u003e\n\u003cli\u003e$17.9B 2024 sales: disruption impact magnified\u003c\/li\u003e\n\u003cli\u003eLate-2025 tariffs: hundreds of millions margin risk\u003c\/li\u003e\n\u003cli\u003eOngoing sourcing shifts distract leadership\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOral‑care reliance, weak e‑commerce \u0026amp; $794M write‑down squeeze margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eConcentration in oral care (~45% of 2024 net sales) and slower innovation risk margins (oral-care ~18% op margin in 2024); late‑2025 $794M skin-health impairment cut GAAP EPS and hurt investor confidence; e-commerce lag (8% of sales in 2024 vs 15–30% peers) and rising private‑label share (US personal‑care 23% in 2025) pressured margins—FY2025 operating margin 16.1%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eOral-care share\u003c\/td\u003e\n\u003ctd\u003e~45% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOral-care op margin\u003c\/td\u003e\n\u003ctd\u003e~18% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eE‑commerce\u003c\/td\u003e\n\u003ctd\u003e8% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS private‑label personal‑care\u003c\/td\u003e\n\u003ctd\u003e23% (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2025 op margin\u003c\/td\u003e\n\u003ctd\u003e16.1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSkin‑health impairment\u003c\/td\u003e\n\u003ctd\u003e$794M (late 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003eColgate-Palmolive SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual Colgate-Palmolive SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality.\u003c\/p\u003e\n\u003cp\u003eThe preview below is taken directly from the full SWOT report you'll get. Purchase unlocks the entire in-depth version.\u003c\/p\u003e\n\u003cp\u003eThis is a real excerpt from the complete document. Once purchased, you’ll receive the full, editable version.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752617881977,"sku":"colgatepalmolive-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/colgatepalmolive-swot-analysis.png?v=1772243035","url":"https:\/\/growthsharematrix.com\/products\/colgatepalmolive-swot-analysis","provider":"Growth Share Matrix","version":"1.0","type":"link"}